David A La Police
Overview
Explore the profile of David A La Police including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
34
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferreira J, Cleland J, Lam C, Anker S, Mehra M, Van Veldhuisen D, et al.
Clin Res Cardiol
. 2021 Mar;
110(10):1554-1563.
PMID: 33686472
Background: Patients with coronary artery disease (CAD) are at increased risk of developing and being hospitalised for heart failure (HFH). However, the risk of HFH versus ischemic events may vary...
2.
Ferreira J, Cleland J, Lam C, Van Veldhuisen D, Byra W, La Police D, et al.
JACC Heart Fail
. 2021 Feb;
9(3):201-211.
PMID: 33549557
Objectives: This study sought to compare patient characteristics, outcomes, and treatment effects among regions in the COMMANDER-HF trial. Background: Globalization of cardiovascular trials increases generalizability. However, regional differences may also...
3.
Ferreira J, Lam C, Anker S, Mehra M, Van Veldhuisen D, Byra W, et al.
Eur J Heart Fail
. 2020 Sep;
23(4):648-656.
PMID: 32959502
Aims: D-dimer is a marker of fibrin degradation that reflects intravascular coagulation. Therefore, plasma concentrations of D-dimer might predict thromboembolic risk and rivaroxaban treatment effect. The aims of this study...
4.
Greenberg B, Neaton J, Anker S, Byra W, Cleland J, Deng H, et al.
JAMA Cardiol
. 2019 Apr;
4(6):515-523.
PMID: 31017637
Importance: Whether anticoagulation benefits patients with heart failure (HF) in sinus rhythm is uncertain. The COMMANDER HF randomized clinical trial evaluated the effects of adding low-dose rivaroxaban to antiplatelet therapy...